Our Core Services & Areas of Expertise
Building the next generation of CRO services, combining clinical expertise, real-world data, biospecimens, and digital intelligence to deliver smarter, more efficient research.
Phase IV & Post-Marketing Research
Post-marketing clinical research, safety monitoring, efficacy validation, and observational programs in real-world clinical settings.
Post-Marketing Safety Monitoring
Systematic monitoring of adverse events and long-term drug tolerability across extensive, diverse patient cohorts.
Efficacy Validation in Real Practice
Evaluating therapy response rates and clinical endpoints outside the restrictive criteria of pre-marketing trials.
Observational Clinical Programs
Non-interventional study designs documenting standard-of-care patient pathways across multi-center hospital networks.
Regulatory Commitment Studies
Fulfilling post-authorization safety study (PASS) and efficacy study (PAES) regulatory obligations with CDSCO, FDA, and EMA rigor.
Real-World Safety & Vigilance
Tapping into 50+ hospital networks established since 2012, our team coordinates physician investigators to track patient outcomes and generate post-launch evidence swiftly.
Bridging Clinical Trials & Real Practice
Randomized clinical trials provide essential proof of efficacy, but real-world evidence illuminates how therapies perform in heterogeneous, multimorbid patient populations across Indian healthcare settings.
Real-World Evidence & Epidemiology
Designing and managing non-interventional studies, observational cohorts, and epidemiological research reflecting diverse patient populations.
Non-Interventional Study Design
Scientifically rigorous protocols without treatment interference, preserving authentic clinical practice dynamics.
Epidemiological Cohorts
Characterizing incidence, prevalence, risk factors, and prognostic markers across India's diverse demographic landscape.
Treatment Pattern Analytics
Uncovering prescribing habits, medication adherence rates, line of therapy progressions, and clinical switches.
Payor & Market Access Evidence
Generating compelling real-world value dossiers to support reimbursement decisions and health policy dialogues.
Biospecimen-Based Research & Biobanking
Procurement, ethical management, and scientific characterization of high-quality biospecimens supporting diagnostics and translational research.
Extensive Repository Categories
Human Tissues
- • Fresh frozen surgical resections
- • Validated FFPE tissue blocks
- • Histopathology glass slides
- • Matched tumor & adjacent normal
Liquid Biofluids
- • Whole blood & blood derivatives
- • Matched serum & plasma aliquots
- • Cerebrospinal fluid (CSF)
- • Urine, saliva, and synovial fluids
Primary Cells
- • High viability isolated PBMCs
- • Viable buffy coat fractions
- • Bone marrow mononuclear cells (BMMC)
- • CD4+/CD8+ immunomagnetic isolations
Molecular Targets
- • High-molecular-weight genomic DNA
- • Total RNA & small microRNA
- • Circulating cell-free DNA (cfDNA)
- • Extracted total cellular protein
Remnant Clinicals
- • Biomarker-characterized panels
- • Diagnostic concordance cohorts
- • Longitudinal patient follow-up vials
- • Standard clinical pathology archives
Clinical Data Collection & Observational Studies
Systematic clinical data gathering across multi-center networks, supporting real-world insights, disease modeling, and drug performance.
Multi-Center Data Harvesting
Standardized electronic case report forms (eCRF) deployed across hospital sites for high-accuracy data capture.
Disease Modeling & Trajectory
Longitudinal follow-ups tracking biomarker progression, symptom severity, and prognostic transitions over time.
Patient-Reported Outcomes (PRO)
Capturing quality of life, functional status, and treatment satisfaction metrics directly from patients.
Quality Control & Validation
Source data verification, query resolution, automated validation rules, and rigorous auditing ensure analysis readiness.
Structured Real-World Datasets
Our site coordinators work directly inside clinical environments to ensure continuous data entry, eliminating missing values and standardizing clinical definitions.
Longitudinal Registry Power
Patient registries provide the definitive clinical anchor for rare diseases, oncology survivorship, and chronic therapeutic management.
Patient Registries & Outcomes Research
Building disease-specific patient registries and longitudinal outcome studies to evaluate treatment patterns, patient outcomes, and burden of illness.
Disease-Specific Registries
Dedicated longitudinal platforms for Oncology, Neurology, Metabolic Diseases, and autoimmune disorders.
Outcomes & Burden of Illness
Quantifying direct medical costs, disability-adjusted life years, and long-term societal burden across conditions.
Real-World Survival Analysis
Tracking progression-free survival (PFS) and overall survival (OS) in actual clinic settings over extended durations.
Physician Decision Insights
Uncovering treatment heterogeneity, guideline adherence, and unmet medical needs among clinicians.
Diagnostics & Biomarker Research
Facilitating diagnostic validation, biomarker identification, and translational research through coordinated clinical sample collection and Contract Diagnostic Organization (CDO) execution.
IVD & CDx Clinical Trials
Supporting in-vitro diagnostic and companion diagnostic approvals with prospective patient testing.
Analytical & Clinical Specificity
Robust testing of limit of detection (LoD), sensitivity, cross-reactivity, and reproducibility.
Central Laboratory Processing
Fractionation, PBMC isolation, molecular profiling (RT-PCR, NGS, ELISA multiplex, flow cytometry).
Biomarker Discovery Support
Coordinating matched disease and normal cohorts for genetic, proteomic, and metabolic biomarker screening.
Dermatological & Cosmetic Excellence
Conducting human clinical trials under board-certified dermatologists, providing objective biometric evidence and consumer perception data for regulatory and market claims.
Cosmetic & Dermatology Studies
Clinical evaluation, dermatological safety assessments, and efficacy studies for cosmetic products, dermatological formulations, and aesthetic treatments.
Dermatological Safety Assessments
HRIPT (Human Repeat Insult Patch Test), primary irritation patch tests, photo-toxicity, and ocular safety validations.
Clinical Efficacy & Claim Substantiation
Validating anti-aging, hydration, skin barrier repair, depigmentation, elasticity, and sebum regulation claims.
Dermatological Formulations
Clinical trials for therapeutic topicals treating acne, psoriasis, eczema, atopic dermatitis, and alopecia.
Aesthetic & Device Treatments
Assessing lasers, microneedling devices, skin peels, and aesthetic dermal procedures under expert clinical supervision.